Literature DB >> 20406809

Apobec-1 complementation factor modulates liver regeneration by post-transcriptional regulation of interleukin-6 mRNA stability.

Valerie Blanc1, Kimberly J Sessa, Susan Kennedy, Jianyang Luo, Nicholas O Davidson.   

Abstract

Apobec-1 complementation factor (ACF) is the RNA binding subunit of a core complex that mediates C to U RNA editing of apolipoprotein B (apoB) mRNA. Targeted deletion of the murine Acf gene is early embryonic lethal and Acf(-/-) blastocysts fail to implant and proliferate, suggesting that ACF plays a key role in cell growth and differentiation. Here we demonstrate that heterozygous Acf(+/-) mice exhibit decreased proliferation and impaired liver mass restitution following partial hepatectomy (PH). To pursue the mechanism of impaired liver regeneration we examined activation of interleukin-6 (IL-6) a key cytokine required for induction of hepatocyte proliferation following PH. Peak induction of hepatic IL-6 mRNA abundance post PH was attenuated >80% in heterozygous Acf(+/-) mice, along with decreased serum IL-6 levels. IL-6 secretion from isolated Kupffer cells (KC) was 2-fold greater in wild-type compared with heterozygous Acf(+/-) mice. Recombinant ACF bound an AU-rich region in the IL-6 3'-untranslated region with high affinity and IL-6 mRNA half-life was significantly shorter in KC isolated from Acf(+/-) mice compared with wild-type controls. These findings suggest that ACF regulates liver regeneration following PH at least in part by controlling the stability of IL-6 mRNA. The results further suggest a new RNA target and an unanticipated physiological function for ACF beyond apoB RNA editing.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20406809      PMCID: PMC2885197          DOI: 10.1074/jbc.M110.115147

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

Review 1.  Liver regeneration.

Authors:  George K Michalopoulos
Journal:  J Cell Physiol       Date:  2007-11       Impact factor: 6.384

2.  Isolation, characterization and developmental regulation of the human apobec-1 complementation factor (ACF) gene.

Authors:  J O Henderson; V Blanc; N O Davidson
Journal:  Biochim Biophys Acta       Date:  2001-11-11

3.  An AU-rich sequence element (UUUN[A/U]U) downstream of the edited C in apolipoprotein B mRNA is a high-affinity binding site for Apobec-1: binding of Apobec-1 to this motif in the 3' untranslated region of c-myc increases mRNA stability.

Authors:  S Anant; N O Davidson
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

4.  Identification of GRY-RBP as an apolipoprotein B RNA-binding protein that interacts with both apobec-1 and apobec-1 complementation factor to modulate C to U editing.

Authors:  V Blanc; N Navaratnam; J O Henderson; S Anant; S Kennedy; A Jarmuz; J Scott; N O Davidson
Journal:  J Biol Chem       Date:  2000-12-27       Impact factor: 5.157

5.  Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA.

Authors:  A Mehta; M T Kinter; N E Sherman; D M Driscoll
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

6.  Purification and molecular cloning of a novel essential component of the apolipoprotein B mRNA editing enzyme-complex.

Authors:  H Lellek; R Kirsten; I Diehl; F Apostel; F Buck; J Greeve
Journal:  J Biol Chem       Date:  2000-06-30       Impact factor: 5.157

7.  Destabilization of interleukin-6 mRNA requires a putative RNA stem-loop structure, an AU-rich element, and the RNA-binding protein AUF1.

Authors:  Serge Paschoud; Afzal M Dogar; Catherine Kuntz; Barbara Grisoni-Neupert; Larry Richman; Lukas C Kühn
Journal:  Mol Cell Biol       Date:  2006-09-05       Impact factor: 4.272

8.  T cell-derived lymphotoxin regulates liver regeneration.

Authors:  Alexei V Tumanov; Ekaterina P Koroleva; Peter A Christiansen; Mehtab A Khan; Matthew J Ruddy; Byron Burnette; Salvatore Papa; Guido Franzoso; Sergei A Nedospasov; Yang-Xin Fu; Robert A Anders
Journal:  Gastroenterology       Date:  2008-09-18       Impact factor: 22.682

9.  Altered hepatic triglyceride content after partial hepatectomy without impaired liver regeneration in multiple murine genetic models.

Authors:  Elizabeth P Newberry; Susan M Kennedy; Yan Xie; Jianyang Luo; Susan E Stanley; Clay F Semenkovich; Roseanne M Crooke; Mark J Graham; Nicholas O Davidson
Journal:  Hepatology       Date:  2008-10       Impact factor: 17.425

10.  Tristetraprolin mediates interferon-gamma mRNA decay.

Authors:  Rachel L Ogilvie; Julius R Sternjohn; Bernd Rattenbacher; Irina A Vlasova; Darlisha A Williams; Heidi H Hau; Perry J Blackshear; Paul R Bohjanen
Journal:  J Biol Chem       Date:  2009-03-03       Impact factor: 5.157

View more
  13 in total

1.  Hu antigen R and tristetraprolin: counter-regulators of rat apical sodium-dependent bile acid transporter by way of effects on messenger RNA stability.

Authors:  Frank Chen; Ann-Bin Shyu; Benjamin L Shneider
Journal:  Hepatology       Date:  2011-08-09       Impact factor: 17.425

Review 2.  Role of the gut in lipid homeostasis.

Authors:  Nada A Abumrad; Nicholas O Davidson
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

3.  Parent-of-origin effects of A1CF and AGO2 on testicular germ-cell tumors, testicular abnormalities, and fertilization bias.

Authors:  Delphine Carouge; Valerie Blanc; Sue E Knoblaugh; Robert J Hunter; Nicholas O Davidson; Joseph H Nadeau
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-31       Impact factor: 11.205

4.  Regenerative proliferation of differentiated cells by mTORC1-dependent paligenosis.

Authors:  Spencer G Willet; Mark A Lewis; Zhi-Feng Miao; Dengqun Liu; Megan D Radyk; Rebecca L Cunningham; Joseph Burclaff; Greg Sibbel; Hei-Yong G Lo; Valerie Blanc; Nicholas O Davidson; Zhen-Ning Wang; Jason C Mills
Journal:  EMBO J       Date:  2018-02-21       Impact factor: 11.598

Review 5.  RNA binding motif 47 (RBM47): emerging roles in vertebrate development, RNA editing and cancer.

Authors:  Pavan Kumar Mysuru Shivalingappa; Vaishali Sharma; Anjali Shiras; Sharmila A Bapat
Journal:  Mol Cell Biochem       Date:  2021-09-09       Impact factor: 3.396

6.  A Dedicated Evolutionarily Conserved Molecular Network Licenses Differentiated Cells to Return to the Cell Cycle.

Authors:  Zhi-Feng Miao; Mark A Lewis; Charles J Cho; Mahliyah Adkins-Threats; Dongkook Park; Jeffrey W Brown; Jing-Xu Sun; Joseph R Burclaff; Susan Kennedy; Jianyun Lu; Marcus Mahar; Ilja Vietor; Lukas A Huber; Nicholas O Davidson; Valeria Cavalli; Deborah C Rubin; Zhen-Ning Wang; Jason C Mills
Journal:  Dev Cell       Date:  2020-08-07       Impact factor: 12.270

Review 7.  The multifaceted roles of RNA binding in APOBEC cytidine deaminase functions.

Authors:  Kimberly M Prohaska; Ryan P Bennett; Jason D Salter; Harold C Smith
Journal:  Wiley Interdiscip Rev RNA       Date:  2014-03-24       Impact factor: 9.957

8.  Apobec1 complementation factor overexpression promotes hepatic steatosis, fibrosis, and hepatocellular cancer.

Authors:  Valerie Blanc; Jesse D Riordan; Saeed Soleymanjahi; Joseph H Nadeau; ILKe Nalbantoglu; Yan Xie; Elizabeth A Molitor; Blair B Madison; Elizabeth M Brunt; Jason C Mills; Deborah C Rubin; Irene O Ng; Yeonjung Ha; Lewis R Roberts; Nicholas O Davidson
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

9.  EIYMNVPV Motif is Essential for A1CF Nucleus Localization and A1CF (-8aa) Promotes Proliferation of MDA-MB-231 Cells via Up-Regulation of IL-6.

Authors:  Li Zhou; Jin Hao; Yue Yuan; Rui Peng; Honglian Wang; Dongsheng Ni; Yuping Gu; Liyuan Huang; Zhaomin Mao; Zhongshi Lyu; Yao Du; Zhicheng Liu; Yiman Li; Pan Ju; Yaoshui Long; Jianing Liu; Qin Zhou
Journal:  Int J Mol Sci       Date:  2016-05-25       Impact factor: 5.923

10.  Apobec-1 Complementation Factor (A1CF) Inhibits Epithelial-Mesenchymal Transition and Migration of Normal Rat Kidney Proximal Tubular Epithelial Cells.

Authors:  Liyuan Huang; Honglian Wang; Yuru Zhou; Dongsheng Ni; Yanxia Hu; Yaoshui Long; Jianing Liu; Rui Peng; Li Zhou; Zhicheng Liu; Zhongshi Lyu; Zhaomin Mao; Jin Hao; Yiman Li; Qin Zhou
Journal:  Int J Mol Sci       Date:  2016-02-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.